Shaping the future of cardiovascular disease by 3D printing applications in stent technology and its clinical outcomes

M Ullah, A Bibi, A Wahab, S Hamayun… - Current Problems in …, 2023 - Elsevier
Cardiovascular disease (CVD) is a leading cause of death worldwide. In recent years, 3D
printing technology has ushered in a new era of innovation in cardiovascular medicine. 3D …

Stent thrombosis and restenosis with contemporary drug-eluting stents: predictors and current evidence

F Condello, C Spaccarotella, S Sorrentino… - Journal of clinical …, 2023 - mdpi.com
Iterations in stent technologies, advances in pharmacotherapy, and awareness of the
implications of implantation techniques have markedly reduced the risk of stent failure, both …

P2Y12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions

F Gragnano, R Mehran, M Branca, A Franzone… - Journal of the American …, 2023 - jacc.org
Background It remains unclear whether P2Y12 inhibitor monotherapy preserves ischemic
protection while limiting bleeding risk compared with dual antiplatelet therapy (DAPT) after …

Nitric oxide releasing nanomaterials for cardiovascular applications

TA Tabish, MJ Crabtree, HE Townley… - Basic to Translational …, 2024 - jacc.org
A central paradigm of cardiovascular homeostasis is that impaired nitric oxide (NO)
bioavailability results in a wide array of cardiovascular dysfunction including incompetent …

Drug-eluting stents: Technical and clinical progress

M Koźlik, J Harpula, PJ Chuchra, M Nowak… - Biomimetics, 2023 - mdpi.com
Drug-eluting stents (DES) demonstrated superior efficacy when compared to bare metal
stents and plain-old balloon angioplasty and are nowadays used in almost all percutaneous …

3D printing technology and its revolutionary role in stent implementation in cardiovascular disease

MA Khan, N Khan, M Ullah, S Hamayun… - Current Problems in …, 2024 - Elsevier
Cardiovascular disease (CVD), exemplified by coronary artery disease (CAD), is a global
health concern, escalating in prevalence and burden. The etiology of CAD is intricate …

Is there an advantage of ultrathin-strut drug-eluting stents over second-and third-generation drug-eluting stents?

FA Gherasie, C Valentin, SS Busnatu - Journal of personalized medicine, 2023 - mdpi.com
In patients undergoing percutaneous coronary intervention, the second-generation drug-
eluting stents (DES) are considered the gold standard of care for revascularization. By …

[HTML][HTML] Drug-eluting stents for coronary artery disease in the perspective of bibliometric analysis

Y Zeng, J Xu, Y Deng, X Li, W Chen… - Frontiers in …, 2024 - frontiersin.org
Drug-eluting stents (DES) play a crucial role in treating coronary artery disease (CAD) by
preventing restenosis. These stents are coated with drug carriers that release …

Angiotensin receptor-neprilysin inhibition in patients with STEMI vs NSTEMI

DL Mann, J Nicolas, B Claggett, ZM Miao… - Journal of the American …, 2024 - jacc.org
Background Patients who sustain an acute myocardial infarction (AMI), including ST-
segment elevation myocardial infarction (STEMI) and non–ST-segment elevation myocardial …

[HTML][HTML] A review on the use of finite element simulations for structural analyses of coronary stenting: What can we do nowadays and what do we need to move forward …

L Antonini, G Poletti, G Pennati, L Petrini - European Journal of Mechanics …, 2023 - Elsevier
In silico studies to perform structural analyses of coronary stenting have attracted the
attention of many researchers in the last 25 years. As a consequence, the finite element …